Beyond AirXAIR +5.66%27 Market Cap is $6.19 Mil as of Jun. 28, 2026. GuruFocus rates XAIR with a GF Score™ of 27/100 and a GF Value™ of $9.75 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 868 Medical Devices & Instruments companies, Beyond Air ranks worse than 89.86% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Beyond Air's share price for the quarter that ended in Dec. 2025 was $0.726. Beyond Air's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 8.40 Mil. Therefore, Beyond Air's market cap for the quarter that ended in Dec. 2025 was $6.10 Mil.
Beyond Air's quarterly market cap
increased
from Jun. 2025 ($16.17 Mil) to Sep. 2025 ($18.50 Mil) but then
declined
from Sep. 2025 ($18.50 Mil) to Dec. 2025 ($6.10 Mil).
Beyond Air's annual market cap
declined
from Mar. 2023 ($207.50 Mil) to Mar. 2024 ($79.87 Mil) and
declined
from Mar. 2024 ($79.87 Mil) to Mar. 2025 ($22.50 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Beyond Air's Enterprise Value for Today is $18.30 Mil.
Beyond Air (NAS:XAIR) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Beyond Air Market Cap Related Terms
Beyond Air Market Cap Historical Data
* Premium members only.
The historical data trend for Beyond Air's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Beyond Air's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beyond Air Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Beyond Air's Market Cap distribution charts can be found below:
* The bar in red indicates where Beyond Air's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Beyond Air's Market Cap for the fiscal year that ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beyond Air (XAIR) has a Market Cap of $6.19 Mil as of Jun. 28, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Beyond Air and its competitors. According to the industry distribution chart, Beyond Air ranks #780 out of 868 companies in the Medical Devices & Instruments industry, placing it in the top 89.9%.
Is Beyond Air's Market Cap too high?
Beyond Air's current Market Cap is $6.19 Mil. The Medical Devices & Instruments industry median Market Cap is 118.39. Beyond Air's value of $6.19 Mil is 94.8% below this industry median. Based on the distribution chart, Beyond Air ranks #780 out of 868 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Beyond Air has a GF Score™ of 27/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Beyond Air's Market Cap compare to LUDG and INBS?
According to the Medical Devices & Instruments industry distribution chart, Beyond Air ranks #780 out of 868 companies for Market Cap. This places Beyond Air in the lower half of its industry. The industry median Market Cap is 118.39. Beyond Air's value of $6.19 Mil is 94.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 118.39, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beyond Air's current Market Cap of $6.19 Mil is 94.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Beyond Air and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 118.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beyond Air's current Market Cap is $6.19 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beyond Air stock overvalued right now?
Based on GuruFocus' analysis, Beyond Air (XAIR) is currently considered Possible Value Trap. The stock's GF Value™ is $9.75, compared to a current price of $0.49 — trading 95% below its estimated fair value. The current Market Cap is $6.19 Mil and 94.8% below the Medical Devices & Instruments industry median of 118.39. Beyond Air's overall GF Score™ is 27/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Beyond Air (XAIR), the current Market Cap is $6.19 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beyond Air (XAIR) Overvalued in 2026?
Based on GuruFocus' analysis, Beyond Air stock appears to be undervalued.
The current stock price of $0.49 is trading 95% below its estimated GF Value™ of $9.75.
GuruFocus considers Beyond Air to be Possible Value Trap.
Key valuation signals for XAIR:
Market Cap: $6.19 Mil
GF Value™: $9.75 vs. price of $0.49 (95% below fair value)
Industry Position: 94.8% below the Medical Devices & Instruments median (#780 of 868)
No single metric tells the full story. See the XAIR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
27GF Score
Get the complete analysis for XAIR
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XAIR has been successfully added to your 
